Hygromycin B (100 mg/mL)

Product#: DCP-HMB2G
$393.79
Availability:
Ships in 1-2 Weeks

Hygromycin B (100 mg/mL)

Cat No.: DCP-HMB2G

Size: 20 mL (20 x 1mL)

Sterile; Ultrapure, Filtered 0.22-micron membrane Once.  

Description:

Hygromycin B Solution (100 mg/mL in HEPES) is a ready-to-use, sterile aminoglycoside antibiotic formulation optimized for robust selection and maintenance of hygromycin-resistant cells in mammalian, plant, fungal, bacterial, and yeast systems. The antibiotic is produced by Streptomyces hygroscopicus and supplied as an active 100 mg/mL solution in sterile HEPES, ensuring excellent physiological compatibility and minimal impact on culture conditions.

Hygromycin B is an aminoglycoside antibiotic that inhibits protein synthesis by interfering with ribosomal translocation and inducing misreading of the mRNA template. It stabilizes tRNA binding at the ribosomal A-site, prevents proper mRNA/tRNA translocation, and ultimately blocks polypeptide chain elongation, leading to rapid cell death in non-resistant cells. Resistance is conferred by hygromycin B phosphotransferase, encoded by hyg/hph genes, which inactivate the antibiotic via phosphorylation and allow selective survival of successfully transfected or transduced cells.

* Do not autoclave: Hygromycin B solutions must not be autoclaved as this will destroy antibiotic activity.

Applications

  • Selection of stable transfectants or transduced cells expressing hygromycin-resistance markers.
  • Maintenance of established hygromycin-resistant mammalian, insect, plant, fungal, yeast, or bacterial cell lines.
  • Dual-selection strategies in combination with G418, blasticidin S, or other antibiotics for generating multi-resistant cell lines.
  • Gene expression, vector integration, and genome-editing studies (including CRISPR/Cas9) requiring stringent, long-term selection.
  • Antiviral research, exploiting hygromycin B’s ability to selectively enter virus-infected cells with increased membrane permeability and inhibit translation.

Advantages:

  • 100 mg/mL Hygromycin B in HEPES, sterile-filtered and ready to use.
  • Broad-spectrum activity against bacteria, fungi, and higher eukaryotic cells lacking hygromycin resistance.
  • Ideal for selection and long-term maintenance of cells carrying hygromycin resistance genes (hyg or hph).
  • Compatible with CRISPR/Cas9 and other genome-editing workflows requiring stable integration and selection.
  • Manufactured as a cell culture–tested solution with high purity and validated potency.

Quality Control:

  • Appearance: Clear, Colorless Liquid.
  • pH: 7.4
  • Sterility: Filtered 0.22-micron membrane Once.
  • DNase activity: None was detected after incubation of plasmid DNA and this product for 18 hr at room temperature.
  • RNase activity: No RNase activity was detected after incubation of ribosomal RNA and this product for 18 hr at room temperature. 

Storage and Shelf Life:

  • Storage: 4 ℃ in the dark.
  • Shelf life: 2 years
  • Do not freeze.

CUSTOMIZATION:  Please INQUIRE if other concentrations, additions of chemicals/compounds/proteins/supplements, different pH, and modifications are needed.

All DiagnoCine Precision Sterile buffers are filtered-sterilized with a 0.1-micron filtration two times and 0.04-micron filtration one time. Thus, mycoplasma contamination is prevented.  The smallest size mycoplasma type can be about 0.2 microns.

* This product is manufactured under ISO 13485-certified and CE-approved facilities (Suppliers of DiagnoCine Precision). All final packaging, quality assurance, and testing are done at the DiagnoCine R&D and Quality Testing Center.  All specific customization requests and assembly were accomplished at DiagnoCine Precision in Totowa, New Jersey, USA.

Satisfaction
Quality Rating
Value Rating
Style Rating
X